Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 227

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 227
---
 validity of the securities being registered or upon other legal matters in connection with the registration or offering of the Class A Ordinary Shares was employed on a contingency basis, or had, or is to receive, in connection with the offering, a substantial interest, direct or indirect, in the registrant. Nor was any such person connected with the registrant as a promoter, managing or principal Underwriter, voting trustee, director, officer, or employee.

<div align='center'>DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION</div>

Insofar as indemnification for liabilities arising under the Securities Act, may be permitted to Living Homeopathy’s directors, officers or persons controlling Living Homeopathy, Living Homeopathy has been advised that it is the SEC’s opinion that such indemnification is against public policy as expressed in such act and is, therefore, unenforceable.

<div align='center'>WHERE YOU CAN FIND ADDITIONAL INFORMATION</div>

We have filed a registration statement on
Form F-1, including exhibits with the SEC, under the Securities Act with respect to the Class A Ordinary Shares to be sold in this
offering. This prospectus, which constitutes a part of the registration statement on Form F-1, does not contain all of the information
contained in the registration statement. You should read our registration statements and their exhibits and schedules for further information
with respect to us and the Class A Ordinary Shares.

Immediately upon the completion of this offering, we will be subject to periodic reporting and other informational requirements of the Exchange Act, as applicable to foreign private issuers. Accordingly, Living Homeopathy will be required to file reports, including annual reports on Form 20-F, and other information with the SEC. As a foreign private issuer, Living Homeopathy is exempt from the rules of the Exchange Act prescribing the furnishing and content of proxy statements to shareholders under the federal proxy rules contained in Sections 14(a), (b) and (c) of the Exchange Act, and Living Homeopathy’s executive officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.

All information filed with the SEC can be obtained over the internet
at the SEC’s website at www.sec.gov. You can request copies of documents, upon payment of a duplicating fee, by writing to the SEC.

No dealers, salesperson or other person is authorized to give any information or to represent anything not contained in this prospectus. You must not rely on any unauthorized